Figure 1 Host factors influencing gut bacterial growth

Slides:



Advertisements
Similar presentations
Microbial growth: chapter 6
Advertisements

Breton J, et al Brenda Quijas
Nat. Rev. Endocrinol. doi: /nrendo
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Clinical Nutrition Experimental
Figure 4 The gut microbiota directly influences T-cell differentiation
Figure 4 Interactions between adipose, the microbiome and kidney
Figure 1 Differential immune responses in the gut (oral tolerance)
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Figure 2 The microbiome–gut–brain axis
Independence Day for IgA
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Gut Microbiota: The Link to Your Second Brain
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Polysaccharides from plants and mushrooms
Figure 1 Oestrogen biosynthesis and production sites in the body
Figure 3 Satiety, bacterial growth and satiety hormone release
Yusuf Talha Tamer, Erdal Toprak  Molecular Cell 
Figure 4 Bacterial growth dynamic-based model of appetite control
Nat. Rev. Endocrinol. doi: /nrendo
Warfare between Host Immunity and Bacterial Weapons
Figure 2 Microbiota and osteoimmunology
Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.
Inflammatory Bowel Disease as a Model for Translating the Microbiome
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Endocrinol. doi: /nrendo
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease
Nitzan Koppel, Emily P. Balskus  Cell Chemical Biology 
Nat. Rev. Endocrinol. doi: /nrendo
The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease  Stephen M. Collins, Premsyl.
Figure 1 The role of CTLA4 and PD1 in T cell activation
Nat. Rev. Endocrinol. doi: /nrendo
Volume 23, Issue 2, Pages (February 2016)
Figure 1 Influence of diet on gut microbiota and blood pressure
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Pro-inflammatory and anti-inflammatory effects of the gut microbiota Figure 2 | Pro-inflammatory and anti-inflammatory effects of the gut microbiota.
Figure 1 Brain–gut axis Brain–gut axis. Schematic of the brain–gut axis, including inputs from the gut microbiota, the ENS, the immune system and the external.
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Regulation of hepatic glucose metabolism by the gut, brain and liver Figure 1 | Regulation of hepatic glucose metabolism by the gut, brain and.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 Potential interplay between physiological
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Endocrinol. doi: /nrendo
Modeling Human Nutrition Using Human Embryonic Stem Cells
Microbes, Microbiota, and Colon Cancer
H-NS2-FLAG expression is upregulated in DMEM and M9 minimal medium and when cells enter the stationary growth phase. H-NS2-FLAG expression is upregulated.
Figure 4 Local species pools that contribute to the
Figure 2 Gut microbial gene content and development of T1DM
The Impact of the Gut Microbiota on Human Health: An Integrative View
Volume 172, Issue 6, Pages (March 2018)
Homeostasis and Inflammation in the Intestine
Dan R. Littman, Eric G. Pamer  Cell Host & Microbe 
Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance  Ankur Singh, Ilana Brito, Jan Lammerding 
Figure 1 Colonic inflammation in IBD and link to the gut microbiota
Targeting Antibiotic Tolerance, Pathogen by Pathogen
Microbial Molecules from the Multitudes within Us
Inflaming the CD8+ T Cell Response
Judith Behnsen, Manuela Raffatellu  Immunity 
Figure 3 Global iodine status and mandatory salt iodization
Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism
(A) Metabolic niches in the gut microbiome.
Figure 1 Infection and resistance in urological practice
Presentation transcript:

Figure 1 Host factors influencing gut bacterial growth Figure 1 | Host factors influencing gut bacterial growth. a | Typical growth dynamics of a large versus small bacterial population illustrate the different durations of the exponential growth phase (Exp). b | Key host-related factors influencing the balance between stimulation and inhibition of the bacterial cell number in the gut. The role of the immune system is not shown, but it contributes by stabilizing the autochthonic community and neutralizing pathogenic invaders. c | Presence of chemical and digestive factors and the transit time along the gastrointestinal tract might underlie the increasing rostro–caudal gradient of bacterial content225. In the upper gut, the transit time is, apparently, shorter than the time necessary for the bacterial population to reach the stationary growth phase (Stat), as calculated using the formula: t (min) = G (generation time, 20 min, assumed based on in vitro experiments and in vivo infusions) × 3.3 log (minimal bacterial number in the Stat phase, that is, 109) / bacterial number before multiplication (for example, 103 in the duodenum). Figure 1a modified from Cell Metab. 23 (2), Breton, J.et al. Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. 324–334 © (2016), with permission from Elsevier. Figure 1a modified from Cell Metab. 23 (2), Breton, J. et al. Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. 324–334 © (2016), with permission from Elsevier. Fetissov, S. O. (2016) Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.150